Vmbook Online ordering

Encore Capital Group Inc

Company Name: Tekla Life Sciences Investors

Stock Ticker: ECPI (not ECPG, please verify the correct ticker before proceeding with further research)

Exchange: NASDAQ

Tekla Life Sciences Investors is a closed-end fund focused on the life sciences sector. The company invests primarily in public and private companies involved in biotechnology, pharmaceutical, and life science industries. Their portfolio includes both equity and debt securities of these companies.

Key Metrics & Financial Information:

1. Net Assets: As of the most recent quarter (Q3 2021), the company's net assets were approximately $3.57 billion.

2. Earnings and Dividends: Tekla Life Sciences Investors has a complex earnings structure due to its closed-end fund status. They pay distributions to shareholders that may include ordinary income, capital gains, and return of capital. The most recent distribution (as of Q3 2021) was $0.23 per share, paid on October 29, 2021. However, the distribution components and the yield may vary; it is essential to check the company's distribution history and statements for the most accurate information.

3. Growth: Historically, the company's net asset value (NAV) has had fluctuations due to market conditions and the performance of the life sciences sector. Between Q3 2016 and Q3 2021, the NAV has ranged from approximately $15.61 per share to $21.34 per share. Since Q3 2016, the NAV has increased by about 36.7%, while the S&P 500 has grown by approximately 81.3%.

It is important to note that the company's performance may differ from major indices due to its specific sector focus, investment strategy, and closed-end fund structure. Interested investors should carefully evaluate the company's financial statements, reports, and other publicly available information before making investment decisions.